Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
19,10 € ↑0,40 (2,14%)
2026-06-05
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionSegall Bryant & Hamill, Llc
Latest Disclosed Ownership140,111 shares
Latest Disclosed Value $ 2,772,797
Segall Bryant & Hamill, Llc reports 1.98% decrease in ownership of PDC / Pediatrix Medical Group, Inc.

On May 15, 2026 - Segall Bryant & Hamill, Llc filed a 13F-HR form disclosing ownership of 140,111 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $2,521,998 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 142,947 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of -1.98% during the quarter. The current value of the position is $2,676,120 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 140,111 -2,836 -1.98 2,773 -9.32 0.0450
2026-02-13 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 142,947 -769 -0.54 3,058 27.00 0.0414
2025-11-12 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 143,716 -504,961 -77.84 2,407 -74.14 0.0321
2025-08-12 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 648,677 -86,109 -11.72 9,309 -12.58 0.1307
2025-05-02 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 734,786 -47,093 -6.02 10,647 3.79 0.1632
2025-02-11 2024-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 781,879 -463,071 -37.20 10,258 -28.90 0.1411
2024-11-08 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,244,950 -74,289 -5.63 14,429 44.86 0.1967
2024-08-14 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,319,239 -245,431 -15.69 9,960 -36.53 0.1766
2024-05-15 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,564,670 -31,569 -1.98 15,694 5.71 0.2941
2024-02-14 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,596,239 -168,981 -9.57 14,845 -33.83 0.2861
2023-11-09 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,765,220 339,013 23.77 22,436 10.70 0.2596
2023-08-14 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,426,207 624,479 77.89 20,266 184,136.36 0.2120
2023-05-15 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 801,728 -11,184 -1.38 12 -99.91 0.1289
2023-02-14 2022-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 812,912 -7,580 -0.92 12,079 -10.83 0.1348
2022-11-14 2022-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 820,492 15,645 1.94 13,546 -19.90 0.1614
2022-08-15 2022-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 804,847 90,580 12.68 16,912 0.82 0.1904
2022-05-13 2022-03-31 13F MEDNAX COM 58502B106 714,267 790 0.11 16,774 -13.59 0.1605
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 713,477 30,131 4.41 19,412 -0.06 0.1794
2021-12-30 2021-09-30 13F/A-1 MEDNAX COM 58502B106 683,346 12,830 1.91 19,424 -3.92 0.1858
2021-11-03 2021-09-30 13F MEDNAX COM 58502B106 683,346 12,830 19,424 0.1880
2021-08-12 2021-06-30 13F MEDNAX COM 58502B106 670,516 9,815 1.49 20,216 20.12 0.1962
2021-05-13 2021-03-31 13F MEDNAX COM 58502B106 660,701 -1,048,984 -61.36 16,830 -59.89 0.1664
2021-02-12 2020-12-31 13F MEDNAX COM 58502B106 1,709,685 -248,651 -12.70 41,956 31.58 0.4667
2020-11-13 2020-09-30 13F MEDNAX COM 58502B106 1,958,336 1,011,324 106.79 31,886 96.92 0.4330
2020-08-14 2020-06-30 13F MEDNAX COM 58502B106 947,012 226,517 31.44 16,192 93.08 0.2721
2020-05-14 2020-03-31 13F MEDNAX COM 58502B106 720,495 617,387 598.78 8,386 192.60 0.1704
2020-02-11 2019-12-31 13F MEDNAX COM 58502B106 103,108 103,108 2,866 0.0445
2019-08-14 2019-06-30 13F Mednax COM 58502B106 0 -130,139 -100.00 0 -100.00
2019-05-15 2019-03-31 13F Mednax COM 58502B106 130,139 130,139 3,538 0.0549
2018-05-15 2018-03-31 13F Mednax COM 58502B106 0 -20,050 -100.00 0 -100.00
2018-02-15 2017-12-31 13F Mednax COM 58502B106 20,050 -321 -1.58 1,071 21.98 0.0236
2017-11-14 2017-09-30 13F Mednax -Common Stock 58502B106 20,371 -240 -1.16 878 -29.42 0.0204
2017-08-14 2017-06-30 13F Mednax -Common Stock 58502B106 20,611 -8,585 -29.40 1,244 -38.60 0.0293
2017-05-12 2017-03-31 13F Mednax -Common Stock 58502B106 29,196 942 3.33 2,026 7.59 0.0490
2017-02-14 2016-12-31 13F Mednax -Common Stock 58502B106 28,254 -976 -3.34 1,883 -2.74 0.0473
2016-11-14 2016-09-30 13F Mednax -Common Stock 58502B106 29,230 2,287 8.49 1,936 -0.77 0.0497
2016-08-10 2016-06-30 13F Mednax -Common Stock 58502B106 26,943 318 1.19 1,951 13.36 0.0514
2016-05-12 2016-03-31 13F Mednax -Common Stock 58502B106 26,625 4,916 22.64 1,721 10.60 0.0426
2016-02-12 2015-12-31 13F Mednax -Common Stock 58502B106 21,709 -271 -1.23 1,556 -7.82 0.0374
2015-11-12 2015-09-30 13F Mednax -Common Stock 58502B106 21,980 551 2.57 1,688 6.30 0.0411
2015-08-12 2015-06-30 13F Mednax -Common Stock 58502B106 21,429 21,429 1,588 0.0355
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.